Exopharm Ltd - ESG Rating & Company Profile powered by AI
This analysis of Exopharm Ltd is prepared by All Street Sevva using leading NLP. The report of Exopharm Ltd employs data points from across the internet and also from available disclosures by Exopharm Ltd. If you work at Exopharm Ltd and you wish to licence your Sustainability rating, please get in touch.
Exopharm Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 8.0, social score of 6.4 and governance score of 8.0.
7.5
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 149 | Torrent Pharmaceuticals Ltd | 7.6 | High |
| 149 | Virbac SA | 7.6 | High |
| 160 | Exopharm Ltd | 7.5 | High |
| 160 | C4X Discovery Holdings PLC | 7.5 | High |
| 160 | Ascentage Pharma Group International | 7.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Exopharm Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Exopharm Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Exopharm Ltd report the average age of the workforce?
Sign up for free to unlockDoes Exopharm Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Exopharm Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Exopharm Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Exopharm Ltd offer flexible work?
Sign up for free to unlockDoes Exopharm Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Exopharm Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Exopharm Ltd conduct supply chain audits?
Sign up for free to unlockDoes Exopharm Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Exopharm Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Exopharm Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Exopharm Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Exopharm Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Exopharm Ltd disclose water use targets?
Sign up for free to unlockDoes Exopharm Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Exopharm Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Exopharm Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Exopharm Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Exopharm Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Exopharm Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Exopharm Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Exopharm Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Exopharm Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Exopharm Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Exopharm Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Exopharm Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Exopharm Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Exopharm Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Exopharm Ltd disclose its waste policy?
Sign up for free to unlockDoes Exopharm Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Exopharm Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Exopharm Ltd disclose energy use targets?
Sign up for free to unlockDoes Exopharm Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Exopharm Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Exopharm Ltd
These potential risks are based on the size, segment and geographies of the company.
Exopharm Limited, a clinical-stage company, develops transformative medicines based upon extracellular vesicles (EVs) in Australia. The company's technology includes extracellular vesicle positioning system that allows specific molecules to be attached to the surface of exosomes to guide them to target tissues or cell types; leveraging oligonucleotide packing for amplified dosing, which enables specific RNA molecules to be preferentially loaded into exosomes as a therapeutic cargo; ligand-based exosome affinity purification that isolates and purifies exosomes from biofluids like blood and cell culture media. Its engineered EVs products comprise Fortrexo CoV for the treatment of SARS-CoV-2 infection; Cognevo for the treatment of neuro degeneration; and PlexoDox for the treatment of cancer. Exopharm Limited has a research collaboration with Showa Denko Materials Co., Ltd. The company was incorporated in 2013 and is based in Melbourne, Australia.